Purchase Order 75N91022P00851

Award Date 9/7/22
Potential Completion Date 9/6/23
Potential Value $150K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Monrovia, CA 91016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $249,997 contract is for the identification of anti-HIV lead compounds as part of NIAID's in vitro testing resource for HIV therapeutics and topical microbicides. Southern Research Institute, which holds multiple federal indefinite...
This is a cost-plus-fixed-fee Delivery Order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit research organization, with a potential value of $146,812.16. The contract is for the contractor to test interventional agents in laboratory and specialized assays with the objective of identifying and characterizing at least one agent with activity. This...
This is a Cost Plus Fixed Fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, which has a ceiling value of $516,234.16, is for the identification of anti-HIV therapeutics and topical microbicides. It falls under NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The $684,610.00 contract is for the identification of anti-HIV therapeutics and topical microbicides, which falls under NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. The contract has a...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to the non-profit organization Essential Access Health (doing business as Cfhc). The $730,541.42 cost-no-fee delivery order is for a Female Contraceptive Clinical Trial: Vaginal Ring. The award has no set-aside designation. This delivery order is part of a broader indefinite delivery contract (IDC) with a potential value of $5...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit organization, to carry out activities required for the optimization, development, and synthesis of lead candidates and analogs related to in vitro testing of HIV therapeutics and topical microbicides. The contract has a potential value of $1,997,772.21 and a completion date of February...
The prime contractor, Advanced Bioscience Laboratories, Inc., has been awarded a $455,080 cost plus fixed fee Delivery Order contract by the National Institutes of Health National Institute of Allergy and Infectious Diseases to support the characterization of drug substances in the MPT VR drug product. This includes analyzing the particle characteristics, such as size, morphology, and dispersion throughout the ring layers, of the drug substance following compounding under the Comprehensive...
This is a $403,478.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for conducting hit-to-lead progression studies on investigational agents for the treatment of HIV. This work will be performed under NIAID's Preclinical Services for HIV Therapeutics indefinite...
This is a delivery order awarded under the National Institute of Child Health and Human Development's "Nonclinical Contraceptive Vaginal Gel Development Services" Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The $775,022.00 cost-plus-fixed-fee order was awarded to the non-profit research institute SRI International to provide research and development services related to a novel non-hormonal contraceptive vaginal gel. The order includes a subcontract with Mississippi...

This firm-fixed-price purchase order for $150,000.00 was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to the non-profit Oak Crest Institute of Science. The contract is for the procurement of vaginal rings for the slow delivery of the SAMT-247 microbicide in support of HIV prevention research on Indian rhesus macaques at the Vaccine Branch of the Center for Cancer Research. The contract does not have a set-aside designation and is scheduled for completion on September 6, 2023. Oak Crest Institute of Science has previously provided various goods and services to federal agencies, including formulation development for multipurpose prevention technologies and research on sustained release technologies for HIV prevention and treatment.

Generated 3/23/24, 2:19 AM